Abivax (ABVX) Convertible Debt (2023 - 2025)

Abivax's Convertible Debt history runs 3 years deep, the most recent figure standing at $86.5 million for Q3 2025.

• In Q3 2025, Convertible Debt changed N/A year-over-year to $86.5 million; the TTM figure through Sep 2025 stood at $86.5 million (changed N/A YoY), while the FY2024 annual figure was $121.8 million, up 46.96% from the prior year.
• Convertible Debt was $86.5 million for Q3 2025 at Abivax, down from $138.9 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $138.9 million in Q2 2025 to a low of $82.9 million in Q4 2023.
• Historically, Convertible Debt has averaged $114.7 million across 3 years, with a median of $125.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Convertible Debt soared 46.96% in 2024, then rose 7.8% in 2025.
• A 3-year view of Convertible Debt shows it stood at $82.9 million in 2023, then jumped by 46.96% to $121.8 million in 2024, then dropped by 29.0% to $86.5 million in 2025.
• The last three Convertible Debt figures came in at $86.5 million (Q3 2025), $138.9 million (Q2 2025), and $129.0 million (Q1 2025), per Business Quant data.